Baseline PSMA PET results may inform patient selection and willingness to enter trials Use of off-study PSMA PET during a trial may lead to treatment changes or study withdrawal Non-uniform use of ...
The trial design for ARASTEP is highlighted in the following schema: Two special considerations for ARASTEP are that all patients have maximally treated pelvic disease and that metastasis directed ...
The prospective, multi-center phase 3 PRIMARY randomized trial tested the additive diagnostic value of PSMA PET imaging in high-risk men with negative or equivocal MRI in the diagnosis of significant ...
Phase 2b data show RAD101 amino acid PET hits 90% concordance, helping distinguish brain metastasis recurrence from ...
Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to introduce ...
A "gold standard" scan to improve the detection of prostate cancer will soon be offered in East Yorkshire, according to a ...
Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to announce that ...
Lung cancer used to have grim outcomes but earlier detection is improving those odds. A new combined procedure with diagnosis ...
While smoking remains the leading risk factor, other contributors include secondhand smoke, air pollution, radon exposure and ...
This event will host a critical forum where Italian-American scientist Dario Crosetto has submitted a 500-word abstract and 2-page summary detailing a breakthrough in radiation signal detection. TBPET ...
Before this past fall, if you lived close to the Bemidji area and your doctor recommended a PET/CT scan, it was a bit of a challenge to get that done. “Historically, we’ve had a mobile PET/CT that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results